The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Enzyme-Catalyzed Activation of Anticancer Prodrugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083491 · Cited by 3,464
Casarett and Doull's Toxicology: The Basic Science of Poisons
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_2 · Cited by 3,302
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 2×
“, from 5 4 pmol/mg for 2D6 to 96 51 pmol/mg for 3A determined from 60 individuals (Shimada et al., 1994).”
BackgroundChemistry of Biologically Important Synthetic Organoselenium Compounds
Mugesh, G., du Mont, W.-W., & Sies, H. (2001) · Chemical Reviews · doi:10.1021/cr000426w · Cited by 1,689
Miwa, M., Ura, M., Nishida, M., Sawada, N., Ishikawa, T., Mori, K., Shimma, N., Umeda, I., & Ishitsuka, H. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00058-6 · Cited by 1,240
Chemistry and Biochemistry of Flavoenzymes
Muller, F. (2018) · CRC Press eBooks · doi:10.1201/9781351070577 · Cited by 1,214
Moolten, F. L. (1986) · PubMed · Cited by 972
Etoposide: four decades of development of a topoisomerase II inhibitor
Hande, K. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00228-7 · Cited by 949
Welt, F. G. P., & Edelman, E. R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)90003-x · Cited by 863
Glutathione-S-transferase family of enzymes
Strange, R. C., Spiteri, M. A., Ramachandran, S., & Fryer, A. A. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00206-8 · Cited by 831
Cited by
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Glutathione-Mediated Delivery and Release Using Monolayer Protected Nanoparticle Carriers
Hong, R., Han, G., Fernández, J. M., Kim, B.-J., Forbes, N. S., & Rotello, V. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056726i · Cited by 817
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Alfarouk, K. O., Stock, C.-M., Taylor, S., Walsh, M., Muddathir, A. K., Verduzco, D., Bashir, A. H. H., Mohammed, O. Y., Elhassan, G. O., Harguindey, S., et al. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0221-1 · Cited by 665
Weekley, C. M., & Harris, H. H. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60272a · Cited by 629
Cytochrome P450 pharmacogenetics and cancer
Rodriguez-Antona, C., & Ingelman-Sundberg, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209377 · Cited by 575
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Gold nanoparticle platforms as drug and biomacromolecule delivery systems
Duncan, B., Kim, C., & Rotello, V. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.004 · Cited by 469
Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles
Agasti, S. S., Chompoosor, A., You, C.-C., Ghosh, P., Kim, C. K., & Rotello, V. M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900591t · Cited by 434
Enzymes involved in the bioconversion of ester-based prodrugs
Liederer, B. M., & Borchardt, R. T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20542 · Cited by 377
Human Carboxylesterase Isozymes: Catalytic Properties and Rational Drug Design
Imai, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.173 · Cited by 359
Mechanical Force-Triggered Drug Delivery
Zhang, Y., Yu, J., Bomba, H. N., Zhu, Y., & Gu, Z. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00369 · Cited by 354
Click and release: bioorthogonal approaches to “on-demand” activation of prodrugs
Ji, X., Pan, Z., Yu, B., De La Cruz, L. K., Zheng, Y., Ke, B., & Wang, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00395e · Cited by 335
Enzyme‐MOF Nanoreactor Activates Nontoxic Paracetamol for Cancer Therapy
Lian, X., Huang, Y., Zhu, Y., Fang, Y., Zhao, R., Joseph, E., Li, J., Pellois, J., & Zhou, H. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201801378 · Cited by 283
Stem and progenitor cell-mediated tumor selective gene therapy
Aboody, K. S., Najbauer, J., & Danks, M. K. (2008) · Gene Therapy · doi:10.1038/gt.2008.41 · Cited by 270
A review of drug release mechanisms from nanocarrier systems
Ding, C., & Li, Z. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.03.130 · Cited by 268
Multimodal drug delivery using gold nanoparticles
Kim, C.-K., Ghosh, P., & Rotello, V. M. (2009) · Nanoscale · doi:10.1039/b9nr00112c · Cited by 267
Alkylating agents and cancer therapy
Ralhan, R., & Kaur, J. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.9.1061 · Cited by 147
Domain Motion in Cytochrome P450 Reductase
Ellis, J., Gutierrez, A., Barsukov, I. L., Huang, W.-C., Grossmann, J. G., & Roberts, G. C. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054304 · Cited by 140
Targeting the Delivery of Glycan-Based Paclitaxel Prodrugs to Cancer Cells via Glucose Transporters
Lin, Y.-S., Tungpradit, R., Sinchaikul, S., An, F.-M., Liu, D.-Z., Phutrakul, S., & Chen, S.-T. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006257 · Cited by 120
Structure and function of mammalian aldehyde oxidases
Terao, M., Romão, M. J., Leimkühler, S., Bolis, M., Fratelli, M., Coelho, C., Santos-Silva, T., & Garattini, E. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1683-1 · Cited by 112
(2016) · Profiles of Drug Substances, Excipients and Related Methodology · doi:10.1016/bs.podrm.2015.12.002 · Cited by 48
Metadata
- Authors
- Rooseboom, M., Commandeur, J. N. M., & Vermeulen, N. P. E.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 56
- Issue
- 1
- Pages
- 53-102
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2155635155
- Cited by
- 497
- References
- 164
- FWCI
- 23.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.